Company research
COMPASS Pathways plc
CIK 1816590Updated Sep 24, 2026
SecurityCMPS · NASDAQ · adr
Name history
Compass Rx Ltd. · through Aug 10, 2020
CMPS price & chart
Loading TradingView…
NASDAQ:CMPS on TradingView ↗In the news
CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions ↗
Recent filings
144 filing
144 filing
S-3ASR filing
Results of Operations and Financial Condition
Items 2.02, 9.01
10-Q filing
Show 5 more recent filings
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
4 filing
4 filing
4 filing
4 filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 210,349,000Source | 213,666,000Source | 275,987,000Source | 197,294,000Source |
| Property, Plant and Equipment, NetUSD | — | 189,000Source | 423,000Source | 617,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 149,608,000Source | 165,081,000Source | 220,198,000Source | 143,206,000Source |
| Assets, CurrentUSD | 191,490,000Source | 201,291,000Source | 261,296,000Source | 191,651,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 41,503,000Source | 35,821,000Source | 39,535,000Source | 47,695,000Source |
| Operating Lease, Right-of-Use AssetUSD | 3,424,000Source | 2,006,000Source | 4,306,000Source | 2,006,000Source |
| Other Assets, NoncurrentUSD | 11,684,000Source | 6,595,000Source | 7,049,000Source | 327,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 263,197,000Source | 58,971,000Source | 50,243,000Source | 16,014,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 973,000Source | 702,000Source | — | — |
| Additional Paid in CapitalUSD | 783,562,000Source | 704,919,000Source | 621,645,000Source | 458,825,000Source |
| Retained Earnings (Accumulated Deficit)USD | -822,594,000Source | -534,732,000Source | -379,610,000Source | -261,146,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -14,789,000Source | -16,194,000Source | -16,926,000Source | -16,867,000Source |
| Stockholders' Equity Attributable to ParentUSD | -52,848,000Source | 154,695,000Source | 225,744,000Source | 181,280,000Source |
| Liabilities and EquityUSD | 210,349,000Source | 213,666,000Source | 275,987,000Source | 197,294,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 247,795,000Source | 34,016,000Source | 19,604,000Source | 15,596,000Source |
| Operating Lease, Liability, CurrentUSD | 2,110,000Source | 1,725,000Source | 2,411,000Source | 1,510,000Source |
| Accounts Payable, CurrentUSD | 15,222,000Source | 12,283,000Source | 5,892,000Source | 4,761,000Source |
| Operating Lease, Liability, NoncurrentUSD | 1,292,000Source | 303,000Source | 1,882,000Source | 418,000Source |
| Additional Financial Items | ||||
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | 28,757,000Source | — |
| Long-term Debt, Current MaturitiesUSD | 17,523,000Source | 5,513,000Source | — | — |
| Long-term Debt, Excluding Current MaturitiesUSD | 14,110,000Source | 24,652,000Source | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | — | — | 242,000Source | 330,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 13,590,000Source | 19,517,000Source | 17,277,000Source | 13,123,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | 2,034,000Source | 6,590,000Source | 864,000Source | 2,497,000Source |
| Deferred Income Tax Expense (Benefit)USD | 22,000Source | -437,000Source | -1,113,000Source | -1,457,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -157,240,000Source | -119,186,000Source | -97,376,000Source | -105,451,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | 0Source | -64,000Source | -596,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | 0Source | 66,000Source | 596,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 0Source | 239,000Source | 265,000Source | 85,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 140,712,000Source | 63,824,000Source | 173,830,000Source | 1,040,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -15,483,000Source | -55,168,000Source | 77,257,000Source | -129,966,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 149,987,000Source | 165,470,000Source | 220,638,000Source | 143,381,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 3,050,000Source | 3,070,000Source | 1,254,000Source | — |
| Income Taxes Paid, NetUSD | 755,000Source | — | — | — |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 1,045,000Source | 194,000Source | 867,000Source | -24,959,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 13,590,000Source | 19,517,000Source | 17,277,000Source | 13,123,000Source |
| DepreciationUSD | 216,000Source | 233,000Source | — | — |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | 0Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 3,471,000Source | -1,032,000Source | 3,686,000Source | 821,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | 1,152,000Source | -755,000Source | 2,617,000Source | -1,141,000Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | 0Source | -40,000Source | — |
| General and Administrative ExpenseUSD | 60,601,000Source | 59,166,000Source | 49,401,000Source | 45,350,000Source |
| Income Tax Expense (Benefit)USD | -2,473,000Source | 1,594,000Source | 780,000Source | 408,000Source |
| InterestExpenseNonoperatingUSD | 4,517,000Source | 4,479,000Source | — | — |
| Investment Income, InterestUSD | 7,182,000Source | 8,268,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -287,862,000Source | -155,122,000Source | -118,464,000Source | -91,505,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -118,464,000Source | -91,505,000Source |
| Nonoperating Income (Expense)USD | -111,298,000Source | 24,677,000Source | 19,235,000Source | 19,306,000Source |
| Operating ExpensesUSD | 179,037,000Source | 178,205,000Source | 136,919,000Source | 110,403,000Source |
| Other Nonoperating Income (Expense)USD | 1,380,000Source | 823,000Source | — | — |
| Payments to Acquire InvestmentsUSD | — | — | — | 0Source |
| Proceeds from Issuance of Common StockUSD | 140,357,000Source | 26,219,000Source | 144,935,000Source | 440,000Source |
| Proceeds from Issuance of Long-term DebtUSD | — | 0Source | 29,585,000Source | — |
| Proceeds from Stock Options ExercisedUSD | 35,000Source | 221,000Source | 2,000Source | 401,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -179,037,000Source | -178,205,000Source | -136,919,000Source | -110,403,000Source |
| Other Nonoperating Income (Expense)USD | 1,380,000Source | 823,000Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -290,335,000Source | -153,528,000Source | -117,684,000Source | -91,097,000Source |
| Income Tax Expense (Benefit)USD | -2,473,000Source | 1,594,000Source | 780,000Source | 408,000Source |
| Net Income (Loss) Attributable to ParentUSD | -287,862,000Source | -155,122,000Source | -118,464,000Source | -91,505,000Source |
| Earnings Per Share, BasicUSD per share | -3.08Source | -2.3Source | -2.32Source | -2.16Source |
| Earnings Per Share, DilutedUSD per share | -3.08Source | -2.3Source | -2.32Source | -2.16Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 93,504,836Source | 67,482,902Source | 51,028,024Source | 42,436,292Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 93,504,836Source | 67,482,902Source | 51,028,024Source | 42,436,292Source |
| Interest Expense (non-operating)USD | 4,517,000Source | 4,479,000Source | — | — |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | -2,495,000Source | 2,031,000Source | 1,893,000Source | 1,865,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | — | — | — | 0Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | 3,471,000Source | -1,032,000Source | 3,686,000Source | 821,000Source |
| General and Administrative ExpenseUSD | 60,601,000Source | 59,166,000Source | 49,401,000Source | 45,350,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -293,932,000Source | -156,711,000Source | -120,320,000Source | -92,841,000Source |
| Interest ExpenseUSD | — | — | 2,204,000Source | — |
| Interest Expense, DebtUSD | 4,500,000Source | 4,500,000Source | 2,200,000Source | — |
| Investment Income, InterestUSD | 7,182,000Source | 8,268,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -118,464,000Source | -91,505,000Source |
| Nonoperating Income (Expense)USD | -111,298,000Source | 24,677,000Source | 19,235,000Source | 19,306,000Source |
| Operating ExpensesUSD | 179,037,000Source | 178,205,000Source | 136,919,000Source | 110,403,000Source |
| Research and Development ExpenseUSD | 118,436,000Source | 119,039,000Source | 87,518,000Source | 65,053,000Source |
Filing attachments
a8-kdated7july2026ex991.htm · 8-K · 2026-07-07
EX-99.1 2 a8-kdated7july2026ex991.htm EX-99.1 a8-kdated7july2026ex991 © Compass Pathways | 1 Compass Pathways Phase 3 COMP006 data review July 7, 2026 © Compass Pathways | 2 Cautionary Note Regarding Forward-Looking Statements This presentation includes “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. In some cases, you can identify forward-looking statements by terms such as “believe,” “continue,” “could,” “estimate,” “ex…
Read attachment ↗